N-(2-Methoxyphenyl)thiobenzamide (19). (80%), mp 78–79 °C
(ethyl acetate–hexanes) (lit.,5 121–122 °C); dH 3.91 (3H, s, OCH3),
6.99 (2H, m, 3,5-H), 7.21 (1H, m, 4-H), 7.46 (3H, m, 3,4,5-H),
7.83 (2H, m, 2,6-H), 9.13 (1H, d, J 7, 6-H), 9.64 (1H, s, N–H);
dC 56.4, 110.7, 120.8, 121.9, 126.9, 127.2, 129.0, 131.4, 144.5,
150.3, 196.5.
5-Methoxy-2-phenylbenzothiazole (12). (AIBN cyclization:
benzene, 1.5 h, 84%), mp 75–77 °C (ethyl acetate–hexanes)
(Found: C, 69.49; H, 4.78; N, 5.80%. Calc. for C14H11NOS: C,
69.68; H, 4.59; N, 5.80%); mmax/cm−1 1597, 1462, 1256; dH 3.87
(3H, s, OCH3), 7.04 (1H, dd, J 3 and 9, 6-H), 7.45 (3H, m,
3,4,5-H), 7.55 (1H, d, J 2, 4-H), 7.68 (1H, d, J 9, 7-H), 8.05
(2H, m, 2,6-H); dC 56.0, 106.1, 115.9, 122.2, 127.4, 127.8, 129.4,
131.2, 134.2, 155.9, 159.6, 169.6.
General procedure for the Jacobson synthesis
To the thiobenzamide (0.1 g) in ethanol (0.5 mL) was added
1.5 M sodium hydroxide (7 mL). The solution was cooled in
an ice–water bath and freshly prepared (20%) aq. potassium
ferricyanide (2–3 molar equiv.) added. The mixture was stirred
at room temperature for 1 day, the mixture neutralized with 1 M
HCl and extracted with ethyl acetate. The organic layer was
dried (Na2SO4), the solvent removed in vacuo and the residue
purified by column chromatography or recrystallization from
ethanol or ethyl acetate–hexanes to give white needles.
N-(4-Amino-2,5-dimethoxyphenyl)thiobenzamide (7a)
To
a
solution of N-(2,5-dimethoxy-4-nitrophenyl)thio-
benzamide (1d) (2.6 g, 8.6 mmol) in ethanol (40 mL) was added
tin pellets (3 g, 25.3 mmol) and conc. hydrochloric acid (10 mL).
The mixture was heated at reflux for 3 h, cooled to room temper-
ature, poured into water (100 mL) and the pH adjusted to 7 with
10% aq. sodium hydroxide. The resultant yellow precipitate was
collected by filtration, purified by column chromatography and
recrystallized from ethyl acetate–hexanes as fine orange crystals
(1.2 g, 50%), mp 104–106 °C (ethyl acetate–hexanes); mmax/cm−1
3361, 1535, 1266; dH 3.79 (3H, s, OCH3), 3.84 (3H, s, OCH3), 6.35
(1H, s, 3-H), 7.43 (3H, m, 3,4,5-H), 7.80 (2H, m, 2,6-H), 8.89
(1H, s, 6-H), 9.58 (1H, s, N–H); dC 56.7, 56.8, 99.0, 106.3, 119.8,
127.1, 129.0, 131.1, 135.2, 140.0, 144.5, 145.4, 193.5.
General procedure for the AIBN-induced cyclization of
thiobenzamides
To a solution of the thiobenzamide (0.1 g) in benzene, toluene
or nitrobenzene (10 mL) was added AIBN (1.1 molar equiv.)
and the mixture was stirred at reflux for the appropriate time.
The solvent was removed in vacuo, the crude product eluted
through a neutral alumina column and recrystallized from
ethyl acetate–hexanes or ethanol. When nitrobenzene was used
as solvent, this was removed by eluting the reaction mixture
through a silica column with hexanes followed by ethyl acetate.
The ethyl acetate fraction was concentrated and recrystallized
from ethyl acetate–hexanes or ethanol.
Tosylation of 7a and 15
To a solution of the amino compound (200 mg) in dry pyridine
(5 mL) was added toluene-p-sulfonyl chloride (1.2 equiv.). The
resulting mixture was stirred at room temperature for 12 h,
toluene (15 mL) added and the solvent removed in vacuo. The
product was then recrystallized from ethyl acetate–hexanes.
N-[2,5-Dimethoxy-4-(p-tolylsulfonylamino)phenyl]thio-
benzamide (7b). Orange crystals (quant.), mp 145–146 °C (lit.,4
146–149 °C).
5,6-Dimethoxy-2-phenylbenzothiazole (6). (Jacobson syn-
thesis: 15%; AIBN cyclization: nitrobenzene, 15 min, 93%), mp
145–146 °C (ethanol) (lit.,5 142–144 °C); dH 3.91 (3H, s, OCH3),
3.93 (3H, s, OCH3), 7.58 (3H, m, 3,4,5-H), 7.66 (1H, s, 7-H),
7.73 (1H, s, 4-H), 8.07 (2H, m, 2,6-H); dC 56.1, 56.3, 103.7,
105.8, 126.7, 126.9, 129.7, 131.0, 133.6, 148.2, 148.9, 165.2.
N-[2-Methoxy-4-(p-tolylsulfonylamino)phenyl]benzamide
(16). Orange-brown crystals (quant.), mp 172–173 °C (Found:
C, 63.28; H, 4.87; N, 7.07%. Calc. for C21H20N2O4S: C, 63.62;
H, 5.03; N, 7.07%); mmax/cm−1 3427, 1531, 1203; dH 2.37 (3H, s,
CH3), 3.91 (3H, s, OCH3), 6.85 (2H, m, 3,5-H), 7.22 (2H, d, J
8, tosyl), 7.50 (3H, m, 3,4,5-H), 7.69 (2H, d, J 8, tosyl), 7.88
(2H, m, 2,6-H), 8.16 (1H, s, 6-H), 8.51 (1H, s, N–H); dC 21.9,
56.5, 114.9, 118.4,127.4, 127.5,127.7, 127.8, 129.2, 130.0, 132.3,
144.0, 146.4, 166.0.
6-Amino-5-methoxy-2-phenylbenzothiazole (8a). (Jacobson
synthesis: <10%; AIBN cyclization: nitrobenzene, 15 min,
98%), mp 150–151 °C (ethyl acetate–hexanes); mmax/cm−1 3461,
1474, 1327; dH 3.87 (3H, s, OCH3), 7.03 (1H, s, 7-H), 7.39 (4H, m,
3,4,5-H and 4-H), 7.91 (2H, m, 2,6-H); dC 54.7, 102.9, 103.6,
125.8, 127.9, 129.0, 133.1, 134.9, 146.4, 146.9, 164.5.
N-(4-Acetylamino-2,5-dimethoxyphenyl)thiobenzamide
(7c). To a solution of N-(4-amino-2,5-dimethoxyphenyl)thio-
benzamide 7a (0.20 g, 0.7 mmol) in dry pyridine (5 mL) was
added acetic anhydride (0.06 mL, 0.8 mmol). The resulting
mixture was stirred at room temperature for 12 h, toluene
(15 mL) added and the solvent removed in vacuo. The product
was then recrystallized from ethyl acetate–hexanes as yellow
crystals (quant., 0.23 g), mp 174–175 °C (Found: C, 61.58; H,
5.54; N, 8.56%. Calc. for C17H18N2O3S: C, 61.80; H, 5.49; N,
8.47%); mmax/cm−1 3419, 1587, 1542, 1210; dH 2.21 (3H, s, CH3),
3.90 (6H, s, 2 × OCH3), 7.46 (3H, m, 3,4,5-H), 7.86 (3H, m,
2,6-H and N–H), 8.25 (1H, s, 3-H), 9.21 (1H, s, 6-H), 9.75 (1H,
s, N–H); dC 25.4, 56.8, 56.9, 103.3, 104.5, 124.3, 125.7, 127.1,
129.1, 131.4, 140.7, 144.0, 144.5, 168.8, 194.9.
5-Methoxy-2-phenyl-6-(p-tolylsulfonylamino)benzothiazole
(8b). (Jacobson synthesis: <10%; AIBN cyclization: toluene,
12 h, 81%), mp 184–186 °C (lit.,4 184–186 °C).
6-Acetylamino-5-methoxy-2-phenylbenzothiazole (8c).
(Jacobson synthesis: <5%; AIBN cyclization: toluene, 12 h,
78%), mp 169–170 °C (ethyl acetate–hexanes) (Found: C, 64.02;
H, 4.68; N, 9.26%. Calc. for C16H14N2O2S: C, 64.41; H, 4.73; N,
9.39%); mmax/cm−1 3422, 3055, 1690, 1262; dH 2.26 (3H, s, CH3),
3.99 (3H, s, OCH3), 7.47 (3H, m, 3,4,5-H), 7.54 (1H, s, 4-H),
7.96 (1H, s, N–H), 8.04 (2H, m, 2,6-H), 8.97 (1H, s, 7-H); dC
25.4, 56.4, 103.9, 111.6, 127.0, 127.5, 128.0, 129.3, 131.0, 134.1,
148.2, 150.5, 168.7.
6-(p-Tolylsulfonylamino)-2-phenylbenzothiazole (18). (AIBN
cyclization: nitrobenzene, 15 min, 82%), mp 209–210 °C (ethyl
acetate–hexanes) (Found: C, 62.96; H, 4.16; N, 7.30%. Calc.
for C20H16N2O2S2: C, 63.13; H, 4.24; N, 7.36%); mmax/cm−1 3433,
1647; dH 2.40 (3H, s, CH3), 6.74 (1H, s, N–H), 7.25 (3H, m, 7-H
and tosyl), 7.52 (3H, m, 3,4,5-H), 7.70 (2H, d, J 8, tosyl), 7.72
(1H, m, 5-H), 7.80 (1H, d, J 9, 4-H), 8.07 (2H, m, 2,6-H); dC
21.9, 116.6, 120.7, 122.5, 127.7, 127.9, 129.5, 130.2, 131.6, 132.7,
133.8, 135.7, 136.5, 144.4, 155.2, 170.1.
N-(2-Methoxy-4-nitrophenyl)benzamide (14). A solution
of the benzamide 13 (3.0 g, 13.2 mmol) in glacial acetic acid
(65 mL) was cooled in an ice–water bath, with stirring. To this
cold solution was added conc. nitric acid (1.2 mL, 26.8 mmol)
in glacial acetic acid (5 mL) and the mixture stirred at ambient
temperature overnight. The mixture was poured into water
(500 mL) and the white precipitate collected by filtration,
purified by column chromatography and obtained as white
crystals (2.16 g, 60%), mp 147–148 °C (lit.,16 149–150 °C).
3 0 4 2
O r g . B i o m o l . C h e m . , 2 0 0 4 , 2 , 3 0 3 9 – 3 0 4 3